Patient package insert (PPI) required for:

Androgens, while requiring patient education, do not have a mandated PPI. They may have specific prescribing information but are not classified under the same regulations that necessitate detailed patient package inserts, which are primarily aimed at medications with broader public health implications.

Corticosteroids are prescribed with careful considerations regarding dosage and potential side effects, yet they do not require PPIs. While patient counseling is essential for these medications, the specific regulatory requirement for PPIs does not apply, as their use is often more acute and less public-facing compared to oral contraceptives.

Oral chemotherapy drugs have specific dispensing requirements and may include patient education materials, but they are not universally required to have PPIs. The regulatory framework for chemotherapy focuses on clinical monitoring and side effect management rather than the standardized PPI format.